Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Now accepting nominations for the Fierce Innovation Awards - Submit your application today
AstraZeneca
Pharma
ICER says AZ's Baxfendy doesn't clear its cost-effectiveness bar
AZ’s newly approved blood pressure drug Baxfendy does not clear the bar for effectiveness relative to its price, says U.S. drug price watchdog ICER.
Kevin Dunleavy
Aug 13, 2026 11:37am
Takeda, Daiichi, Astellas and more—Fierce Pharma Asia
Aug 7, 2026 8:35am
AstraZeneca, CSPC to form manufacturing joint venture
Aug 5, 2026 3:22pm
‘No discussions’ ongoing for AstraZeneca-BMS merger: Reuters
Aug 5, 2026 10:12am
Editor’s Corner: Why an AZ-BMS merger would be a very bad idea
Aug 3, 2026 12:25am
AZ leans on cancer, rare disease muscle in solid Q2
Jul 27, 2026 10:21am
